A detailed history of Peregrine Capital Management LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Peregrine Capital Management LLC holds 420,774 shares of ADMA stock, worth $7.33 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
420,774
Previous 606,233 30.59%
Holding current value
$7.33 Million
Previous $6.78 Million 24.11%
% of portfolio
0.26%
Previous 0.2%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$11.21 - $20.03 $2.08 Million - $3.71 Million
-185,459 Reduced 30.59%
420,774 $8.41 Million
Q2 2024

Jul 29, 2024

SELL
$5.98 - $11.18 $1.25 Million - $2.33 Million
-208,811 Reduced 25.62%
606,233 $6.78 Million
Q1 2024

Apr 26, 2024

SELL
$4.4 - $6.74 $298,931 - $457,908
-67,939 Reduced 7.69%
815,044 $5.38 Million
Q4 2023

Jan 26, 2024

BUY
$3.08 - $4.52 $2.72 Million - $3.99 Million
882,983 New
882,983 $3.99 Million
Q2 2021

Aug 03, 2021

SELL
$1.51 - $2.07 $183,702 - $251,829
-121,657 Closed
0 $0
Q1 2021

May 11, 2021

BUY
$1.67 - $2.95 $203,167 - $358,888
121,657 New
121,657 $214,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.42B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Peregrine Capital Management LLC Portfolio

Follow Peregrine Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peregrine Capital Management LLC with notifications on news.